APO Research
Talk to an analyst

APO RESEARCH · REPORT

AI Clinical Endpoint Assessment Software

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global AI Clinical Endpoint Assessment Software Industry Growth and Trends Forecast to 2032

12 August 2026123 pages

Choose your research edition.

Industry ResearchAI Clinical Endpoint Assessment Software Industry Research Report 2026138 pages · $2,950 USDIndustry Growth & TrendsGlobal AI Clinical Endpoint Assessment Software Industry Growth and Trends Forecast to 2032123 pages · $3,450 USDMarket StructureGlobal AI Clinical Endpoint Assessment Software Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal AI Clinical Endpoint Assessment Software Market Outlook and Growth Opportunities 2026210 pages · $4,250 USDMarket Analysis & ForecastGlobal AI Clinical Endpoint Assessment Software Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

According to APO Research, the global AI Clinical Endpoint Assessment Software market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for AI Clinical Endpoint Assessment Software is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for AI Clinical Endpoint Assessment Software is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for AI Clinical Endpoint Assessment Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the AI Clinical Endpoint Assessment Software market include IQVIA, ICON, Perceptive, Clinical Ink, Koneksa, AiCure, Medable, PathAI and Proscia, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global AI Clinical Endpoint Assessment Software market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The AI Clinical Endpoint Assessment Software market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global AI Clinical Endpoint Assessment Software market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to AI Clinical Endpoint Assessment Software.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global AI Clinical Endpoint Assessment Software market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

AI Clinical Endpoint Assessment Software Market by Company

IQVIA

ICON

Perceptive

Clinical Ink

Koneksa

AiCure

Medable

PathAI

Proscia

Paige

IXICO

Median Technologies

VIDA Diagnostics

Image Analysis Group

QMENTA

Cambridge Cognition

Cogstate

Empatica

Cumulus Neuroscience

Rune Labs

VivoSense

NeuraLight

Aural Analytics

Linus Health

Quibim

Perspectum

Brainomix

Taimei Technology

UnionClin

XincereMed

Clario

Medidata

Signant Health

AI Clinical Endpoint Assessment Software Segment by Type

Medical Imaging Endpoints

Digital Pathology Endpoints

Electronic Clinical Outcome Assessment

Wearable and Physiological Endpoints

Voice, Video and Cognitive Endpoints

Multimodal Endpoints

AI Clinical Endpoint Assessment Software Segment by Application

Oncology

Neurology and Psychiatry

Cardiovascular and Metabolic Diseases

Respiratory Diseases

Musculoskeletal and Immunology

Other Therapeutic Areas

AI Clinical Endpoint Assessment Software Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global AI Clinical Endpoint Assessment Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of AI Clinical Endpoint Assessment Software and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of AI Clinical Endpoint Assessment Software.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of AI Clinical Endpoint Assessment Software companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global AI Clinical Endpoint Assessment Software Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global AI Clinical Endpoint Assessment Software Market Size by Region (2021-2026) & (US$ Million) Table 3. Global AI Clinical Endpoint Assessment Software Market Share by Region (2021-2026) Table 4. Global AI Clinical Endpoint Assessment Software Market Size by Region (2027-2032) & (US$ Million) Table 5. Global AI Clinical Endpoint Assessment Software Market Share by Region (2027-2032) Table 6. Global AI Clinical Endpoint Assessment Software Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global AI Clinical Endpoint Assessment Software Market Size by Type (2021-2026) & (US$ Million) Table 8. Global AI Clinical Endpoint Assessment Software Market Size Share by Type (2021-2026) Table 9. Global AI Clinical Endpoint Assessment Software Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global AI Clinical Endpoint Assessment Software Market Size Share Forecasted by Type (2027-2032) Table 11. North America AI Clinical Endpoint Assessment Software Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America AI Clinical Endpoint Assessment Software Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe AI Clinical Endpoint Assessment Software Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe AI Clinical Endpoint Assessment Software Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific AI Clinical Endpoint Assessment Software Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific AI Clinical Endpoint Assessment Software Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America AI Clinical Endpoint Assessment Software Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America AI Clinical Endpoint Assessment Software Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa AI Clinical Endpoint Assessment Software Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa AI Clinical Endpoint Assessment Software Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global AI Clinical Endpoint Assessment Software Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global AI Clinical Endpoint Assessment Software Market Size by Application (2021-2026) & (US$ Million) Table 23. Global AI Clinical Endpoint Assessment Software Market Size Share by Application (2021-2026) Table 24. Global AI Clinical Endpoint Assessment Software Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global AI Clinical Endpoint Assessment Software Market Size Share Forecasted by Application (2027-2032) Table 26. North America AI Clinical Endpoint Assessment Software Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America AI Clinical Endpoint Assessment Software Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe AI Clinical Endpoint Assessment Software Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe AI Clinical Endpoint Assessment Software Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific AI Clinical Endpoint Assessment Software Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific AI Clinical Endpoint Assessment Software Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America AI Clinical Endpoint Assessment Software Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America AI Clinical Endpoint Assessment Software Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa AI Clinical Endpoint Assessment Software Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa AI Clinical Endpoint Assessment Software Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. AI Clinical Endpoint Assessment Software Industry Trends Table 37. AI Clinical Endpoint Assessment Software Industry Drivers Table 38. AI Clinical Endpoint Assessment Software Industry Opportunities and Challenges Table 39. AI Clinical Endpoint Assessment Software Industry Restraints Table 40. Global AI Clinical Endpoint Assessment Software Revenue by Company (US$ Million) & (2021-2026) Table 41. Global AI Clinical Endpoint Assessment Software Revenue Market Share by Company (2021-2026) Table 42. Global AI Clinical Endpoint Assessment Software Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global AI Clinical Endpoint Assessment Software Key Company Headquarters & Area Served Table 44. Global AI Clinical Endpoint Assessment Software Company, Product Type & Application Table 45. Global AI Clinical Endpoint Assessment Software Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global AI Clinical Endpoint Assessment Software by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. IQVIA Company Information Table 49. IQVIA Business Overview Table 50. IQVIA AI Clinical Endpoint Assessment Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. IQVIA AI Clinical Endpoint Assessment Software Product Portfolio Table 52. IQVIA Recent Development Table 53. ICON Company Information Table 54. ICON Business Overview Table 55. ICON AI Clinical Endpoint Assessment Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. ICON AI Clinical Endpoint Assessment Software Product Portfolio Table 57. ICON Recent Development Table 58. Perceptive Company Information Table 59. Perceptive Business Overview Table 60. Perceptive AI Clinical Endpoint Assessment Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Perceptive AI Clinical Endpoint Assessment Software Product Portfolio Table 62. Perceptive Recent Development Table 63. Clinical Ink Company Information Table 64. Clinical Ink Business Overview Table 65. Clinical Ink AI Clinical Endpoint Assessment Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Clinical Ink AI Clinical Endpoint Assessment Software Product Portfolio Table 67. Clinical Ink Recent Development Table 68. Koneksa Company Information Table 69. Koneksa Business Overview Table 70. Koneksa AI Clinical Endpoint Assessment Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Koneksa AI Clinical Endpoint Assessment Software Product Portfolio Table 72. Koneksa Recent Development Table 73. AiCure Company Information Table 74. AiCure Business Overview Table 75. AiCure AI Clinical Endpoint Assessment Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. AiCure AI Clinical Endpoint Assessment Software Product Portfolio Table 77. AiCure Recent Development Table 78. Medable Company Information Table 79. Medable Business Overview Table 80. Medable AI Clinical Endpoint Assessment Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Medable AI Clinical Endpoint Assessment Software Product Portfolio Table 82. Medable Recent Development Table 83. PathAI Company Information Table 84. PathAI Business Overview Table 85. PathAI AI Clinical Endpoint Assessment Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. PathAI AI Clinical Endpoint Assessment Software Product Portfolio Table 87. PathAI Recent Development Table 88. Proscia Company Information Table 89. Proscia Business Overview Table 90. Proscia AI Clinical Endpoint Assessment Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Proscia AI Clinical Endpoint Assessment Software Product Portfolio Table 92. Proscia Recent Development Table 93. Paige Company Information Table 94. Paige Business Overview Table 95. Paige AI Clinical Endpoint Assessment Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Paige AI Clinical Endpoint Assessment Software Product Portfolio Table 97. Paige Recent Development Table 98. IXICO Company Information Table 99. IXICO Business Overview Table 100. IXICO AI Clinical Endpoint Assessment Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. IXICO AI Clinical Endpoint Assessment Software Product Portfolio Table 102. IXICO Recent Development Table 103. Median Technologies Company Information Table 104. Median Technologies Business Overview Table 105. Median Technologies AI Clinical Endpoint Assessment Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Median Technologies AI Clinical Endpoint Assessment Software Product Portfolio Table 107. Median Technologies Recent Development Table 108. VIDA Diagnostics Company Information Table 109. VIDA Diagnostics Business Overview Table 110. VIDA Diagnostics AI Clinical Endpoint Assessment Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. VIDA Diagnostics AI Clinical Endpoint Assessment Software Product Portfolio Table 112. VIDA Diagnostics Recent Development Table 113. Image Analysis Group Company Information Table 114. Image Analysis Group Business Overview Table 115. Image Analysis Group AI Clinical Endpoint Assessment Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Image Analysis Group AI Clinical Endpoint Assessment Software Product Portfolio Table 117. Image Analysis Group Recent Development Table 118. QMENTA Company Information Table 119. QMENTA Business Overview Table 120. QMENTA AI Clinical Endpoint Assessment Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. QMENTA AI Clinical Endpoint Assessment Software Product Portfolio Table 122. QMENTA Recent Development Table 123. Cambridge Cognition Company Information Table 124. Cambridge Cognition Business Overview Table 125. Cambridge Cognition AI Clinical Endpoint Assessment Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. Cambridge Cognition AI Clinical Endpoint Assessment Software Product Portfolio Table 127. Cambridge Cognition Recent Development Table 128. Cogstate Company Information Table 129. Cogstate Business Overview Table 130. Cogstate AI Clinical Endpoint Assessment Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 131. Cogstate AI Clinical Endpoint Assessment Software Product Portfolio Table 132. Cogstate Recent Development Table 133. Empatica Company Information Table 134. Empatica Business Overview Table 135. Empatica AI Clinical Endpoint Assessment Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 136. Empatica AI Clinical Endpoint Assessment Software Product Portfolio Table 137. Empatica Recent Development Table 138. Cumulus Neuroscience Company Information Table 139. Cumulus Neuroscience Business Overview Table 140. Cumulus Neuroscience AI Clinical Endpoint Assessment Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 141. Cumulus Neuroscience AI Clinical Endpoint Assessment Software Product Portfolio Table 142. Cumulus Neuroscience Recent Development Table 143. Rune Labs Company Information Table 144. Rune Labs Business Overview Table 145. Rune Labs AI Clinical Endpoint Assessment Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 146. Rune Labs AI Clinical Endpoint Assessment Software Product Portfolio Table 147. Rune Labs Recent Development Table 148. VivoSense Company Information Table 149. VivoSense Business Overview Table 150. VivoSense AI Clinical Endpoint Assessment Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 151. VivoSense AI Clinical Endpoint Assessment Software Product Portfolio Table 152. VivoSense Recent Development Table 153. NeuraLight Company Information Table 154. NeuraLight Business Overview Table 155. NeuraLight AI Clinical Endpoint Assessment Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 156. NeuraLight AI Clinical Endpoint Assessment Software Product Portfolio Table 157. NeuraLight Recent Development Table 158. Aural Analytics Company Information Table 159. Aural Analytics Business Overview Table 160. Aural Analytics AI Clinical Endpoint Assessment Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 161. Aural Analytics AI Clinical Endpoint Assessment Software Product Portfolio Table 162. Aural Analytics Recent Development Table 163. Linus Health Company Information Table 164. Linus Health Business Overview Table 165. Linus Health AI Clinical Endpoint Assessment Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 166. Linus Health AI Clinical Endpoint Assessment Software Product Portfolio Table 167. Linus Health Recent Development Table 168. Quibim Company Information Table 169. Quibim Business Overview Table 170. Quibim AI Clinical Endpoint Assessment Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 171. Quibim AI Clinical Endpoint Assessment Software Product Portfolio Table 172. Quibim Recent Development Table 173. Perspectum Company Information Table 174. Perspectum Business Overview Table 175. Perspectum AI Clinical Endpoint Assessment Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 176. Perspectum AI Clinical Endpoint Assessment Software Product Portfolio Table 177. Perspectum Recent Development Table 178. Brainomix Company Information Table 179. Brainomix Business Overview Table 180. Brainomix AI Clinical Endpoint Assessment Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 181. Brainomix AI Clinical Endpoint Assessment Software Product Portfolio Table 182. Brainomix Recent Development Table 183. Taimei Technology Company Information Table 184. Taimei Technology Business Overview Table 185. Taimei Technology AI Clinical Endpoint Assessment Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 186. Taimei Technology AI Clinical Endpoint Assessment Software Product Portfolio Table 187. Taimei Technology Recent Development Table 188. UnionClin Company Information Table 189. UnionClin Business Overview Table 190. UnionClin AI Clinical Endpoint Assessment Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 191. UnionClin AI Clinical Endpoint Assessment Software Product Portfolio Table 192. UnionClin Recent Development Table 193. XincereMed Company Information Table 194. XincereMed Business Overview Table 195. XincereMed AI Clinical Endpoint Assessment Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 196. XincereMed AI Clinical Endpoint Assessment Software Product Portfolio Table 197. XincereMed Recent Development Table 198. Clario Company Information Table 199. Clario Business Overview Table 200. Clario AI Clinical Endpoint Assessment Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 201. Clario AI Clinical Endpoint Assessment Software Product Portfolio Table 202. Clario Recent Development Table 203. Medidata Company Information Table 204. Medidata Business Overview Table 205. Medidata AI Clinical Endpoint Assessment Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 206. Medidata AI Clinical Endpoint Assessment Software Product Portfolio Table 207. Medidata Recent Development Table 208. Signant Health Company Information Table 209. Signant Health Business Overview Table 210. Signant Health AI Clinical Endpoint Assessment Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 211. Signant Health AI Clinical Endpoint Assessment Software Product Portfolio Table 212. Signant Health Recent Development Table 213. North America AI Clinical Endpoint Assessment Software Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 214. North America AI Clinical Endpoint Assessment Software Market Size by Country (2021-2026) & (US$ Million) Table 215. North America AI Clinical Endpoint Assessment Software Market Share by Country (2021-2026) Table 216. North America AI Clinical Endpoint Assessment Software Market Size Forecast by Country (2027-2032) & (US$ Million) Table 217. North America AI Clinical Endpoint Assessment Software Market Share Forecast by Country (2027-2032) Table 218. Europe AI Clinical Endpoint Assessment Software Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 219. Europe AI Clinical Endpoint Assessment Software Market Size by Country (2021-2026) & (US$ Million) Table 220. Europe AI Clinical Endpoint Assessment Software Market Share by Country (2021-2026) Table 221. Europe AI Clinical Endpoint Assessment Software Market Size Forecast by Country (2027-2032) & (US$ Million) Table 222. Europe AI Clinical Endpoint Assessment Software Market Share Forecast by Country (2027-2032) Table 223. Asia-Pacific AI Clinical Endpoint Assessment Software Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 224. Asia-Pacific AI Clinical Endpoint Assessment Software Market Size by Country (2021-2026) & (US$ Million) Table 225. Asia-Pacific AI Clinical Endpoint Assessment Software Market Share by Country (2021-2026) Table 226. Asia-Pacific AI Clinical Endpoint Assessment Software Market Size Forecast by Country (2027-2032) & (US$ Million) Table 227. Asia-Pacific AI Clinical Endpoint Assessment Software Market Share Forecast by Country (2027-2032) Table 228. Latin America AI Clinical Endpoint Assessment Software Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 229. Latin America AI Clinical Endpoint Assessment Software Market Size by Country (2021-2026) & (US$ Million) Table 230. Latin America AI Clinical Endpoint Assessment Software Market Share by Country (2021-2026) Table 231. Latin America AI Clinical Endpoint Assessment Software Market Size Forecast by Country (2027-2032) & (US$ Million) Table 232. Latin America AI Clinical Endpoint Assessment Software Market Share Forecast by Country (2027-2032) Table 233. Middle East & Africa AI Clinical Endpoint Assessment Software Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 234. Middle East & Africa AI Clinical Endpoint Assessment Software Market Size by Country (2021-2026) & (US$ Million) Table 235. Middle East & Africa AI Clinical Endpoint Assessment Software Market Share by Country (2021-2026) Table 236. Middle East & Africa AI Clinical Endpoint Assessment Software Market Size Forecast by Country (2027-2032) & (US$ Million) Table 237. Middle East & Africa AI Clinical Endpoint Assessment Software Market Share Forecast by Country (2027-2032) Table 238. Research Programs/Design for This Report Table 239. Authors List of This Report Table 240. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. AI Clinical Endpoint Assessment Software Product Image Figure 3. Global AI Clinical Endpoint Assessment Software Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global AI Clinical Endpoint Assessment Software Market Size (2021-2032) & (US$ Million) Figure 5. Global AI Clinical Endpoint Assessment Software Market Share by Region: 2025 VS 2032 Figure 6. Global AI Clinical Endpoint Assessment Software Market Share by Region (2021-2032) Figure 7. North America AI Clinical Endpoint Assessment Software Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe AI Clinical Endpoint Assessment Software Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific AI Clinical Endpoint Assessment Software Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America AI Clinical Endpoint Assessment Software Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa AI Clinical Endpoint Assessment Software Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Medical Imaging Endpoints Image Figure 13. Global Medical Imaging Endpoints Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Digital Pathology Endpoints Image Figure 15. Global Digital Pathology Endpoints Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Electronic Clinical Outcome Assessment Image Figure 17. Global Electronic Clinical Outcome Assessment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Wearable and Physiological Endpoints Image Figure 19. Global Wearable and Physiological Endpoints Market Size YoY Growth (2021-2032) & (US$ Million) Figure 20. Voice, Video and Cognitive Endpoints Image Figure 21. Global Voice, Video and Cognitive Endpoints Market Size YoY Growth (2021-2032) & (US$ Million) Figure 22. Multimodal Endpoints Image Figure 23. Global Multimodal Endpoints Market Size YoY Growth (2021-2032) & (US$ Million) Figure 24. Global AI Clinical Endpoint Assessment Software Market Size Overview by Type (2021-2032) & (US$ Million) Figure 25. Global AI Clinical Endpoint Assessment Software Market Share by Type 2025 VS 2032 Figure 26. North America AI Clinical Endpoint Assessment Software Market Size Share by Type (2021-2032) Figure 27. Europe AI Clinical Endpoint Assessment Software Market Size Share by Type (2021-2032) Figure 28. Asia-Pacific AI Clinical Endpoint Assessment Software Market Size Share by Type (2021-2032) Figure 29. Latin America AI Clinical Endpoint Assessment Software Market Size Share by Type (2021-2032) Figure 30. Middle East and Africa AI Clinical Endpoint Assessment Software Market Size Share by Type (2021-2032) Figure 31. Oncology Image Figure 32. Global Oncology Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Neurology and Psychiatry Image Figure 34. Global Neurology and Psychiatry Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Cardiovascular and Metabolic Diseases Image Figure 36. Global Cardiovascular and Metabolic Diseases Market Size YoY Growth (2021-2032) & (US$ Million) Figure 37. Respiratory Diseases Image Figure 38. Global Respiratory Diseases Market Size YoY Growth (2021-2032) & (US$ Million) Figure 39. Musculoskeletal and Immunology Image Figure 40. Global Musculoskeletal and Immunology Market Size YoY Growth (2021-2032) & (US$ Million) Figure 41. Other Therapeutic Areas Image Figure 42. Global Other Therapeutic Areas Market Size YoY Growth (2021-2032) & (US$ Million) Figure 43. Global AI Clinical Endpoint Assessment Software Market Size Overview by Application (2021-2032) & (US$ Million) Figure 44. Global AI Clinical Endpoint Assessment Software Market Share by Application 2025 VS 2032 Figure 45. North America AI Clinical Endpoint Assessment Software Market Size Share by Application (2021-2032) Figure 46. Europe AI Clinical Endpoint Assessment Software Market Size Share by Application (2021-2032) Figure 47. Asia-Pacific AI Clinical Endpoint Assessment Software Market Size Share by Application (2021-2032) Figure 48. Latin America AI Clinical Endpoint Assessment Software Market Size Share by Application (2021-2032) Figure 49. Middle East and Africa AI Clinical Endpoint Assessment Software Market Size Share by Application (2021-2032) Figure 50. Global Top 5 and 10 AI Clinical Endpoint Assessment Software Players Market Share by Revenue in 2025 Figure 51. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 52. North America AI Clinical Endpoint Assessment Software Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 53. North America AI Clinical Endpoint Assessment Software Market Share by Country: 2021 VS 2025 VS 2032 Figure 54. North America AI Clinical Endpoint Assessment Software Market Share by Country (2021-2032) Figure 55. Europe AI Clinical Endpoint Assessment Software Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Europe AI Clinical Endpoint Assessment Software Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Europe AI Clinical Endpoint Assessment Software Market Share by Country (2021-2032) Figure 58. Asia-Pacific AI Clinical Endpoint Assessment Software Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 59. Asia-Pacific AI Clinical Endpoint Assessment Software Market Share by Country: 2021 VS 2025 VS 2032 Figure 60. Asia-Pacific AI Clinical Endpoint Assessment Software Market Share by Country (2021-2032) Figure 61. Latin America AI Clinical Endpoint Assessment Software Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America AI Clinical Endpoint Assessment Software Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Latin America AI Clinical Endpoint Assessment Software Market Share by Country (2021-2032) Figure 64. Middle East & Africa AI Clinical Endpoint Assessment Software Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 65. Middle East & Africa AI Clinical Endpoint Assessment Software Market Share by Country: 2021 VS 2025 VS 2032 Figure 66. Middle East & Africa AI Clinical Endpoint Assessment Software Market Share by Country (2021-2032) Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Medical Imaging Endpoints
  • Digital Pathology Endpoints
  • Electronic Clinical Outcome Assessment
  • Wearable and Physiological Endpoints
  • Voice, Video and Cognitive Endpoints
  • Multimodal Endpoints
Applications
  • Oncology
  • Neurology and Psychiatry
  • Cardiovascular and Metabolic Diseases
  • Respiratory Diseases
  • Musculoskeletal and Immunology
  • Other Therapeutic Areas
Companies covered
  • IQVIA
  • ICON
  • Perceptive
  • Clinical Ink
  • Koneksa
  • AiCure
  • Medable
  • PathAI
  • Proscia
  • Paige
  • IXICO
  • Median Technologies
  • VIDA Diagnostics
  • Image Analysis Group
  • QMENTA
  • Cambridge Cognition
  • Cogstate
  • Empatica
  • Cumulus Neuroscience
  • Rune Labs
  • VivoSense
  • NeuraLight
  • Aural Analytics
  • Linus Health
  • Quibim
  • Perspectum
  • Brainomix
  • Taimei Technology
  • UnionClin
  • XincereMed
  • Clario
  • Medidata
  • Signant Health

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global AI Clinical Endpoint Assessment Software Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global AI Clinical Endpoint Assessment Software Market Size by Region (2021-2032)
  5. 1.4.1 Global AI Clinical Endpoint Assessment Software Market Size by Region (2021-2026)
  6. 1.4.2 Global AI Clinical Endpoint Assessment Software Market Size by Region (2027-2032)
  7. 1.5 Key Regions AI Clinical Endpoint Assessment Software Market Size (2021-2032)
  8. 1.5.1 North America AI Clinical Endpoint Assessment Software Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe AI Clinical Endpoint Assessment Software Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific AI Clinical Endpoint Assessment Software Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America AI Clinical Endpoint Assessment Software Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa AI Clinical Endpoint Assessment Software Market Size Growth Rate (2021-2032)
2 AI Clinical Endpoint Assessment Software Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Medical Imaging Endpoints
  3. 2.1.2 Digital Pathology Endpoints
  4. 2.1.3 Electronic Clinical Outcome Assessment
  5. 2.1.4 Wearable and Physiological Endpoints
  6. 2.1.5 Voice, Video and Cognitive Endpoints
  7. 2.1.6 Multimodal Endpoints
  8. 2.2 Global AI Clinical Endpoint Assessment Software Market Size by Type
  9. 2.2.1 Global AI Clinical Endpoint Assessment Software Market Size Overview by Type (2021-2032)
  10. 2.2.2 Global AI Clinical Endpoint Assessment Software Historic Market Size Review by Type (2021-2026)
  11. 2.2.3 Global AI Clinical Endpoint Assessment Software Market Size Forecasted by Type (2027-2032)
  12. 2.3 Global AI Clinical Endpoint Assessment Software Market Size by Regions
  13. 2.3.1 North America AI Clinical Endpoint Assessment Software Market Size Breakdown by Type (2021-2026)
  14. 2.3.2 Europe AI Clinical Endpoint Assessment Software Market Size Breakdown by Type (2021-2026)
  15. 2.3.3 Asia-Pacific AI Clinical Endpoint Assessment Software Market Size Breakdown by Type (2021-2026)
  16. 2.3.4 South America AI Clinical Endpoint Assessment Software Market Size Breakdown by Type (2021-2026)
  17. 2.3.5 Middle East and Africa AI Clinical Endpoint Assessment Software Market Size Breakdown by Type (2021-2026)
3 AI Clinical Endpoint Assessment Software Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Oncology
  3. 3.1.2 Neurology and Psychiatry
  4. 3.1.3 Cardiovascular and Metabolic Diseases
  5. 3.1.4 Respiratory Diseases
  6. 3.1.5 Musculoskeletal and Immunology
  7. 3.1.6 Other Therapeutic Areas
  8. 3.2 Global AI Clinical Endpoint Assessment Software Market Size by Application
  9. 3.2.1 Global AI Clinical Endpoint Assessment Software Market Size Overview by Application (2021-2032)
  10. 3.2.2 Global AI Clinical Endpoint Assessment Software Historic Market Size Review by Application (2021-2026)
  11. 3.2.3 Global AI Clinical Endpoint Assessment Software Market Size Forecasted by Application (2027-2032)
  12. 3.3 Global AI Clinical Endpoint Assessment Software Market Size by Regions
  13. 3.3.1 North America AI Clinical Endpoint Assessment Software Market Size Breakdown by Application (2021-2026)
  14. 3.3.2 Europe AI Clinical Endpoint Assessment Software Market Size Breakdown by Application (2021-2026)
  15. 3.3.3 Asia-Pacific AI Clinical Endpoint Assessment Software Market Size Breakdown by Application (2021-2026)
  16. 3.3.4 South America AI Clinical Endpoint Assessment Software Market Size Breakdown by Application (2021-2026)
  17. 3.3.5 Middle East and Africa AI Clinical Endpoint Assessment Software Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 AI Clinical Endpoint Assessment Software Industry Trends
  2. 4.2 AI Clinical Endpoint Assessment Software Industry Drivers
  3. 4.3 AI Clinical Endpoint Assessment Software Industry Opportunities and Challenges
  4. 4.4 AI Clinical Endpoint Assessment Software Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by AI Clinical Endpoint Assessment Software Revenue (2021-2026)
  2. 5.2 Global AI Clinical Endpoint Assessment Software Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global AI Clinical Endpoint Assessment Software Key Company Headquarters & Area Served
  4. 5.4 Global AI Clinical Endpoint Assessment Software Company, Product Type & Application
  5. 5.5 Global AI Clinical Endpoint Assessment Software Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global AI Clinical Endpoint Assessment Software Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 AI Clinical Endpoint Assessment Software Players Market Share by Revenue in 2025
  9. 5.6.3 2025 AI Clinical Endpoint Assessment Software Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 IQVIA
  2. 6.1.1 IQVIA Company Information
  3. 6.1.2 IQVIA Business Overview
  4. 6.1.3 IQVIA AI Clinical Endpoint Assessment Software Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 IQVIA AI Clinical Endpoint Assessment Software Product Portfolio
  6. 6.1.5 IQVIA Recent Developments
  7. 6.2 ICON
  8. 6.2.1 ICON Company Information
  9. 6.2.2 ICON Business Overview
  10. 6.2.3 ICON AI Clinical Endpoint Assessment Software Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 ICON AI Clinical Endpoint Assessment Software Product Portfolio
  12. 6.2.5 ICON Recent Developments
  13. 6.3 Perceptive
  14. 6.3.1 Perceptive Company Information
  15. 6.3.2 Perceptive Business Overview
  16. 6.3.3 Perceptive AI Clinical Endpoint Assessment Software Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Perceptive AI Clinical Endpoint Assessment Software Product Portfolio
  18. 6.3.5 Perceptive Recent Developments
  19. 6.4 Clinical Ink
  20. 6.4.1 Clinical Ink Company Information
  21. 6.4.2 Clinical Ink Business Overview
  22. 6.4.3 Clinical Ink AI Clinical Endpoint Assessment Software Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Clinical Ink AI Clinical Endpoint Assessment Software Product Portfolio
  24. 6.4.5 Clinical Ink Recent Developments
  25. 6.5 Koneksa
  26. 6.5.1 Koneksa Company Information
  27. 6.5.2 Koneksa Business Overview
  28. 6.5.3 Koneksa AI Clinical Endpoint Assessment Software Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Koneksa AI Clinical Endpoint Assessment Software Product Portfolio
  30. 6.5.5 Koneksa Recent Developments
  31. 6.6 AiCure
  32. 6.6.1 AiCure Company Information
  33. 6.6.2 AiCure Business Overview
  34. 6.6.3 AiCure AI Clinical Endpoint Assessment Software Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 AiCure AI Clinical Endpoint Assessment Software Product Portfolio
  36. 6.6.5 AiCure Recent Developments
  37. 6.7 Medable
  38. 6.7.1 Medable Company Information
  39. 6.7.2 Medable Business Overview
  40. 6.7.3 Medable AI Clinical Endpoint Assessment Software Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Medable AI Clinical Endpoint Assessment Software Product Portfolio
  42. 6.7.5 Medable Recent Developments
  43. 6.8 PathAI
  44. 6.8.1 PathAI Company Information
  45. 6.8.2 PathAI Business Overview
  46. 6.8.3 PathAI AI Clinical Endpoint Assessment Software Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 PathAI AI Clinical Endpoint Assessment Software Product Portfolio
  48. 6.8.5 PathAI Recent Developments
  49. 6.9 Proscia
  50. 6.9.1 Proscia Company Information
  51. 6.9.2 Proscia Business Overview
  52. 6.9.3 Proscia AI Clinical Endpoint Assessment Software Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Proscia AI Clinical Endpoint Assessment Software Product Portfolio
  54. 6.9.5 Proscia Recent Developments
  55. 6.10 Paige
  56. 6.10.1 Paige Company Information
  57. 6.10.2 Paige Business Overview
  58. 6.10.3 Paige AI Clinical Endpoint Assessment Software Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Paige AI Clinical Endpoint Assessment Software Product Portfolio
  60. 6.10.5 Paige Recent Developments
  61. 6.11 IXICO
  62. 6.11.1 IXICO Company Information
  63. 6.11.2 IXICO Business Overview
  64. 6.11.3 IXICO AI Clinical Endpoint Assessment Software Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 IXICO AI Clinical Endpoint Assessment Software Product Portfolio
  66. 6.11.5 IXICO Recent Developments
  67. 6.12 Median Technologies
  68. 6.12.1 Median Technologies Company Information
  69. 6.12.2 Median Technologies Business Overview
  70. 6.12.3 Median Technologies AI Clinical Endpoint Assessment Software Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Median Technologies AI Clinical Endpoint Assessment Software Product Portfolio
  72. 6.12.5 Median Technologies Recent Developments
  73. 6.13 VIDA Diagnostics
  74. 6.13.1 VIDA Diagnostics Company Information
  75. 6.13.2 VIDA Diagnostics Business Overview
  76. 6.13.3 VIDA Diagnostics AI Clinical Endpoint Assessment Software Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 VIDA Diagnostics AI Clinical Endpoint Assessment Software Product Portfolio
  78. 6.13.5 VIDA Diagnostics Recent Developments
  79. 6.14 Image Analysis Group
  80. 6.14.1 Image Analysis Group Company Information
  81. 6.14.2 Image Analysis Group Business Overview
  82. 6.14.3 Image Analysis Group AI Clinical Endpoint Assessment Software Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Image Analysis Group AI Clinical Endpoint Assessment Software Product Portfolio
  84. 6.14.5 Image Analysis Group Recent Developments
  85. 6.15 QMENTA
  86. 6.15.1 QMENTA Company Information
  87. 6.15.2 QMENTA Business Overview
  88. 6.15.3 QMENTA AI Clinical Endpoint Assessment Software Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 QMENTA AI Clinical Endpoint Assessment Software Product Portfolio
  90. 6.15.5 QMENTA Recent Developments
  91. 6.16 Cambridge Cognition
  92. 6.16.1 Cambridge Cognition Company Information
  93. 6.16.2 Cambridge Cognition Business Overview
  94. 6.16.3 Cambridge Cognition AI Clinical Endpoint Assessment Software Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 Cambridge Cognition AI Clinical Endpoint Assessment Software Product Portfolio
  96. 6.16.5 Cambridge Cognition Recent Developments
  97. 6.17 Cogstate
  98. 6.17.1 Cogstate Company Information
  99. 6.17.2 Cogstate Business Overview
  100. 6.17.3 Cogstate AI Clinical Endpoint Assessment Software Revenue, Global Share and Gross Margin (2021-2026)
  101. 6.17.4 Cogstate AI Clinical Endpoint Assessment Software Product Portfolio
  102. 6.17.5 Cogstate Recent Developments
  103. 6.18 Empatica
  104. 6.18.1 Empatica Company Information
  105. 6.18.2 Empatica Business Overview
  106. 6.18.3 Empatica AI Clinical Endpoint Assessment Software Revenue, Global Share and Gross Margin (2021-2026)
  107. 6.18.4 Empatica AI Clinical Endpoint Assessment Software Product Portfolio
  108. 6.18.5 Empatica Recent Developments
  109. 6.19 Cumulus Neuroscience
  110. 6.19.1 Cumulus Neuroscience Company Information
  111. 6.19.2 Cumulus Neuroscience Business Overview
  112. 6.19.3 Cumulus Neuroscience AI Clinical Endpoint Assessment Software Revenue, Global Share and Gross Margin (2021-2026)
  113. 6.19.4 Cumulus Neuroscience AI Clinical Endpoint Assessment Software Product Portfolio
  114. 6.19.5 Cumulus Neuroscience Recent Developments
  115. 6.20 Rune Labs
  116. 6.20.1 Rune Labs Company Information
  117. 6.20.2 Rune Labs Business Overview
  118. 6.20.3 Rune Labs AI Clinical Endpoint Assessment Software Revenue, Global Share and Gross Margin (2021-2026)
  119. 6.20.4 Rune Labs AI Clinical Endpoint Assessment Software Product Portfolio
  120. 6.20.5 Rune Labs Recent Developments
  121. 6.21 VivoSense
  122. 6.21.1 VivoSense Company Information
  123. 6.21.2 VivoSense Business Overview
  124. 6.21.3 VivoSense AI Clinical Endpoint Assessment Software Revenue, Global Share and Gross Margin (2021-2026)
  125. 6.21.4 VivoSense AI Clinical Endpoint Assessment Software Product Portfolio
  126. 6.21.5 VivoSense Recent Developments
  127. 6.22 NeuraLight
  128. 6.22.1 NeuraLight Company Information
  129. 6.22.2 NeuraLight Business Overview
  130. 6.22.3 NeuraLight AI Clinical Endpoint Assessment Software Revenue, Global Share and Gross Margin (2021-2026)
  131. 6.22.4 NeuraLight AI Clinical Endpoint Assessment Software Product Portfolio
  132. 6.22.5 NeuraLight Recent Developments
  133. 6.23 Aural Analytics
  134. 6.23.1 Aural Analytics Company Information
  135. 6.23.2 Aural Analytics Business Overview
  136. 6.23.3 Aural Analytics AI Clinical Endpoint Assessment Software Revenue, Global Share and Gross Margin (2021-2026)
  137. 6.23.4 Aural Analytics AI Clinical Endpoint Assessment Software Product Portfolio
  138. 6.23.5 Aural Analytics Recent Developments
  139. 6.24 Linus Health
  140. 6.24.1 Linus Health Company Information
  141. 6.24.2 Linus Health Business Overview
  142. 6.24.3 Linus Health AI Clinical Endpoint Assessment Software Revenue, Global Share and Gross Margin (2021-2026)
  143. 6.24.4 Linus Health AI Clinical Endpoint Assessment Software Product Portfolio
  144. 6.24.5 Linus Health Recent Developments
  145. 6.25 Quibim
  146. 6.25.1 Quibim Company Information
  147. 6.25.2 Quibim Business Overview
  148. 6.25.3 Quibim AI Clinical Endpoint Assessment Software Revenue, Global Share and Gross Margin (2021-2026)
  149. 6.25.4 Quibim AI Clinical Endpoint Assessment Software Product Portfolio
  150. 6.25.5 Quibim Recent Developments
  151. 6.26 Perspectum
  152. 6.26.1 Perspectum Company Information
  153. 6.26.2 Perspectum Business Overview
  154. 6.26.3 Perspectum AI Clinical Endpoint Assessment Software Revenue, Global Share and Gross Margin (2021-2026)
  155. 6.26.4 Perspectum AI Clinical Endpoint Assessment Software Product Portfolio
  156. 6.26.5 Perspectum Recent Developments
  157. 6.27 Brainomix
  158. 6.27.1 Brainomix Company Information
  159. 6.27.2 Brainomix Business Overview
  160. 6.27.3 Brainomix AI Clinical Endpoint Assessment Software Revenue, Global Share and Gross Margin (2021-2026)
  161. 6.27.4 Brainomix AI Clinical Endpoint Assessment Software Product Portfolio
  162. 6.27.5 Brainomix Recent Developments
  163. 6.28 Taimei Technology
  164. 6.28.1 Taimei Technology Company Information
  165. 6.28.2 Taimei Technology Business Overview
  166. 6.28.3 Taimei Technology AI Clinical Endpoint Assessment Software Revenue, Global Share and Gross Margin (2021-2026)
  167. 6.28.4 Taimei Technology AI Clinical Endpoint Assessment Software Product Portfolio
  168. 6.28.5 Taimei Technology Recent Developments
  169. 6.29 UnionClin
  170. 6.29.1 UnionClin Company Information
  171. 6.29.2 UnionClin Business Overview
  172. 6.29.3 UnionClin AI Clinical Endpoint Assessment Software Revenue, Global Share and Gross Margin (2021-2026)
  173. 6.29.4 UnionClin AI Clinical Endpoint Assessment Software Product Portfolio
  174. 6.29.5 UnionClin Recent Developments
  175. 6.30 XincereMed
  176. 6.30.1 XincereMed Company Information
  177. 6.30.2 XincereMed Business Overview
  178. 6.30.3 XincereMed AI Clinical Endpoint Assessment Software Revenue, Global Share and Gross Margin (2021-2026)
  179. 6.30.4 XincereMed AI Clinical Endpoint Assessment Software Product Portfolio
  180. 6.30.5 XincereMed Recent Developments
  181. 6.31 Clario
  182. 6.31.1 Clario Company Information
  183. 6.31.2 Clario Business Overview
  184. 6.31.3 Clario AI Clinical Endpoint Assessment Software Revenue, Global Share and Gross Margin (2021-2026)
  185. 6.31.4 Clario AI Clinical Endpoint Assessment Software Product Portfolio
  186. 6.31.5 Clario Recent Developments
  187. 6.32 Medidata
  188. 6.32.1 Medidata Company Information
  189. 6.32.2 Medidata Business Overview
  190. 6.32.3 Medidata AI Clinical Endpoint Assessment Software Revenue, Global Share and Gross Margin (2021-2026)
  191. 6.32.4 Medidata AI Clinical Endpoint Assessment Software Product Portfolio
  192. 6.32.5 Medidata Recent Developments
  193. 6.33 Signant Health
  194. 6.33.1 Signant Health Company Information
  195. 6.33.2 Signant Health Business Overview
  196. 6.33.3 Signant Health AI Clinical Endpoint Assessment Software Revenue, Global Share and Gross Margin (2021-2026)
  197. 6.33.4 Signant Health AI Clinical Endpoint Assessment Software Product Portfolio
  198. 6.33.5 Signant Health Recent Developments
7 North America
  1. 7.1 North America AI Clinical Endpoint Assessment Software Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America AI Clinical Endpoint Assessment Software Market Size by Country (2021-2026)
  3. 7.3 North America AI Clinical Endpoint Assessment Software Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe AI Clinical Endpoint Assessment Software Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe AI Clinical Endpoint Assessment Software Market Size by Country (2021-2026)
  3. 8.3 Europe AI Clinical Endpoint Assessment Software Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific AI Clinical Endpoint Assessment Software Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific AI Clinical Endpoint Assessment Software Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific AI Clinical Endpoint Assessment Software Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America AI Clinical Endpoint Assessment Software Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America AI Clinical Endpoint Assessment Software Market Size by Country (2021-2026)
  3. 10.3 South America AI Clinical Endpoint Assessment Software Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa AI Clinical Endpoint Assessment Software Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa AI Clinical Endpoint Assessment Software Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa AI Clinical Endpoint Assessment Software Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst